SARS: Lessons Learned from Other Coronaviruses
- 1 December 2003
- journal article
- review article
- Published by Mary Ann Liebert Inc in Viral Immunology
- Vol. 16 (4), 461-474
- https://doi.org/10.1089/088282403771926292
Abstract
The identification of a new coronavirus as the etiological agent of severe acute respiratory syndrome (SARS) has evoked much new interest in the molecular biology and pathogenesis of coronaviruses. This review summarizes present knowledge on coronavirus molecular biology and pathogenesis with particular emphasis on mouse hepatitis virus (MHV). MHV, a member of coronavirus group 2, is a natural pathogen of the mouse; MHV infection of the mouse is considered one of the best models for the study of demyelinating disease, such as multiple sclerosis, in humans. As a result of the SARS epidemic, coronaviruses can now be considered as emerging pathogens. Future research on SARS needs to be based on all the knowledge that coronavirologists have generated over more than 30 years of research.Keywords
This publication has 120 references indexed in Scilit:
- Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 LineageJournal of Molecular Biology, 2003
- The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core ComplexJournal of Virology, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- Clues to the Animal Origins of SARSScience, 2003
- Biologists seek to head off future sources of infectionNature, 2003
- Targeting of HIV- and SIV-Infected Cells by CD4-Chemokine Receptor PseudotypesScience, 1997
- Cytotoxic T Cell–Resistant Variants Are Selected in a Virus-Induced Demyelinating DiseaseImmunity, 1996
- The ns 4 gene of mouse hepatitis virus (MHV), strain A 59 contains two ORFs and thus differs from ns 4 of the JHM and S strainsArchiv für die gesamte Virusforschung, 1993
- Endonuclease (R) subunits of type‐I and type‐III restriction‐modification enzymes contain a helicase‐like domainFEBS Letters, 1991
- Effects of a "new" human respiratory virus in volunteers.BMJ, 1967